Sánchez-Monteagudo, Ana
Ripollés, Edna
Murillo, Oihana
Domènech, Sofia
Álvarez-Sauco, María
Girona, Eva
Sastre-Bataller, Isabel
Bono, Ariadna
García-Villarreal, Luis
Tugores, Antonio
García-García, Francisco
González-Aseguinolaza, Gloria
Berenguer, Marina
Espinós, Carmen http://orcid.org/0000-0003-4435-1809
Funding for this research was provided by:
Fundació Per Amor a l'Art (FPAA-Wilson)
Instituto de Salud Carlos III (PI18/00147, PI21/00103, PI21/00313, INT20/00061, CB06/04/0065)
Ministerio de Ciencia e Innovación (PID2021-124455OB-I00)
Conselleria de Cultura, Educación y Ciencia, Generalitat Valenciana (CIACIF/2021/252)
Article History
Received: 16 April 2024
Accepted: 17 July 2024
First Online: 26 July 2024
Declarations
:
: G. González-Aseguinolaza is Vivet therapeutics employee and shareholder. No sponsor had a role in the study design, the data collection, the analysis and interpretation of data, the writing of the paper or the decision to submit the article for publication.